Abstract:Background Immune checkpoint blockade (ICB) has been approved for the treatment of triple-negative breast cancer (TNBC), since it significantly improved the progression-free survival (PFS). However, only about 10% of TNBC patients could achieve the complete response (CR) to ICB because of the low response rate and potential adverse reactions to ICB. Methods Open datasets from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) were downloaded to perform an unsupervised clustering analysis to identify the immune subtype according to the expression profiles. The prognosis, enriched pathways, and the ICB indicators were compared between immune subtypes. Afterward, samples from the Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) dataset were used to validate the correlation of immune subtype with prognosis. Data from patients who received ICB were selected to validate the correlation of the immune subtype with ICB response. Machine learning models were used to build a visual web server to predict the immune subtype of TNBC patients requiring ICB. Results A total of eight open datasets including 931 TNBC samples were used for the unsupervised clustering. Two novel immune subtypes (referred to as S1 and S2) were identified among TNBC patients. Compared with S2, S1 was associated with higher immune scores, higher levels of immune cells, and a better prognosis for immunotherapy. In the validation dataset, subtype 1 samples had a better prognosis than sub type 2 samples, no matter in overall survival (OS) (p = 0.00036) or relapse-free survival (RFS) (p = 0.0022). Bioinformatics analysis identified 11 hub genes (LCK, IL2RG, CD3G, STAT1, CD247, IL2RB, CD3D, IRF1, OAS2, IRF4, and IFNG) related to the immune subtype. A robust machine learning model based on random forest algorithm was established by 11 hub genes, and it performed reasonably well with area Under the Curve of the receiver operating characteristic (AUC) values = 0.76. An open and free web server based on the random forest model, named as triple-negative breast cancer immune subtype (TNBCIS), was developed and is available from https://immunotypes.shinyapps.io/TNBCIS/ . Conclusion TNBC open datasets allowed us to stratify samples into distinct immunotherapy response subgroups according to gene expression profiles. Based on two novel subtypes, candidates for ICB with a higher response rate and better prognosis could be selected by using the free visual online web server that we designed.

Predicting patient outcomes (TNBC) based on positions of cancer islands and CD8+ T cells using machine learning approach

Predicting Relapse in Patients With Triple Negative Breast Cancer (TNBC) Using a Deep-Learning Approach

Comprehensively analysis of immunophenotyping signature in triple-negative breast cancer patients based on machine learning

Predicting the Prognosis and Immunotherapeutic Response of Triple-Negative Breast Cancer by Constructing a Prognostic Model Based on CD8+ T Cell-Related Immune Genes.

Predicting Tumor Mutation Burden of TNBC Based on Nuclei Scores of Histopathological Images.

Association of Machine Learning Ultrasound Radiomics and Disease Outcome in Triple Negative Breast Cancer.

Artificial Intelligence Learning Landscape of Triple-Negative Breast Cancer Uncovers New Opportunities for Enhancing Outcomes and Immunotherapy Responses

A Machine Learning Model to Predict the Triple Negative Breast Cancer Immune Subtype

A Prognostic Model of Genetic Markers for Triple-Negative Breast Cancer Based on Machine Learning and Bioinformatics Analysis.

Breast cancer outcome prediction with tumour tissue images and machine learning

Ensemble learning-based gene signature and risk model for predicting prognosis of triple-negative breast cancer

Novel immune classification based on machine learning of pathological images predicts early recurrence of hepatocellular carcinoma

Prognostic Prediction of Cancer Based on Radiomics Features of Diagnostic Imaging: The Performance of Machine Learning Strategies

Supervised Machine Learning Predictive Analytics For Triple-Negative Breast Cancer Death Outcomes

Deep Learning-Based System for Automatic Prediction of Triple-Negative Breast Cancer from Ultrasound Images.

Integration of Bioinformatics and Machine Learning to Identify CD8+ T Cell-Related Prognostic Signature to Predict Clinical Outcomes and Treatment Response in Breast Cancer Patients

A Clustering-Based Approach to Predict Outcome in Cancer Patients

Integrating single-cell transcriptomics and machine learning to predict breast cancer prognosis: A study based on natural killer cell-related genes

Model for predicting immunotherapy based on M2 macrophage infiltration in TNBC

Identification of Potential Key Genes and Pathways Predicting Pathogenesis and Prognosis for Triple-Negative Breast Cancer

Prognostic Models for Nonmetastatic Triple-Negative Breast Cancer Based on the Pretreatment Serum Tumor Markers with Machine Learning